Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Operating Leases: 2023-2024

Historic Operating Leases for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $52,000.

  • CG Oncology's Operating Leases rose 4588.73% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 4588.73%. This contributed to the annual value of $52,000 for FY2024, which is 78.69% down from last year.
  • CG Oncology's Operating Leases amounted to $52,000 in FY2024, which was down 78.69% from $244,000 recorded in FY2023.
  • CG Oncology's 5-year Operating Leases high stood at $244,000 for FY2023, and its period low was $52,000 during FY2024.
  • For the 2-year period, CG Oncology's Operating Leases averaged around $148,000, with its median value being $148,000 (2023).
  • Data for CG Oncology's Operating Leases shows a maximum YoY tumbled of 78.69% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Operating Leases stood at $244,000 in 2023, then slumped by 78.69% to $52,000 in 2024.